외상용 제품 시장 규모, 점유율, 동향, 예측 : 제품, 수술 부위, 최종사용자, 지역별(2025-2033년)

The global trauma products market size was valued at USD 9.60 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 15.80 Billion by 2033, exhibiting a CAGR of 5.40% from 2025-2033. North America currently dominates the market, holding a market share of over 46.3% in 2024. The trauma products market share is expanding, driven by the growing aging population, which is more prone to fractures and orthopedic injuries and requires effective care solutions, along with the rising focus on favorable reimbursement policies and government initiatives that encourage the utilization of reliable trauma items.

Trauma is a condition in which a body is damaged, injured, or dislocated by external forces, such as fractures, burns, sprains, dislocations, and strains. Trauma products are composed of innovative instruments, implants, and technologies designed to guarantee patients with musculoskeletal injuries a successful outcome. Pins, metal plates, rods, screws, and wires are commonly used as internal fixators for treating trauma while external fixators include stabilizing frames for bones broken in an accident. The majority of these components are made of metals or metal alloys, such as nickel, cobalt, chromium, and titanium. A variety of injuries that are treated with trauma products include hematomas, hydrocephalus, infections, and fractures of the skull.

Trauma Products Market Trends:

The market is primarily driven by the growing incidences of degenerative bone diseases, such as osteoporosis, Paget's disease, rheumatoid arthritis, and osteoarthritis. This can be attributed to the rising geriatric population that is susceptible to developing these diseases. In addition to this, the increasing adoption of minimally invasive surgeries and the augmenting government support to supply well-equipped instruments to trauma centers are resulting in higher product uptake. The widespread popularity of orthobiologics and regenerative pharmaceuticals in medical biotechnology is also providing an impetus to the market. Besides this, extensive research and development (R&D) activities, collaborations, and mergers and acquisitions (M&A) by key players for developing innovative trauma products are fueling the market. The market is further driven by a considerable rise in the medical expenditure, along with rapid developments in healthcare infrastructure. Some of the other factors creating a positive market outlook include the escalating prevalence of sports injuries and road accidents and the growing awareness regarding advanced trauma devices among patients.

Key Market Segmentation:

Breakup by Product:

• Internal Fixators
• Plates
• Screws
• Nails
• Others
• External Fixators
• Unilateral and Bilateral External Fixators
• Circular External Fixators
• Hybrid External Fixators
• Others

Breakup by Surgical Site:

• Upper Extremities
• Hand and Wrist
• Shoulder
• Elbow
• Lower Extremities
• Hip and Pelvic
• Foot and Ankle
• Knee
• Others

Breakup by End User:

• Hospitals and Trauma Centers
• Ambulatory Surgery Center

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Acumed LLC (Colson Medical Inc.), Arthrex Inc., B. Braun Melsungen AG, Citieffe s.r.l, Double Medical Technology Inc., Enovis Corporation, Globus Medical Inc., Johnson & Johnson, Medartis AG, Orthofix Medical Inc., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.

Key Questions Answered in This Report

• 1.How big is the trauma products market?
• 2.What is the future outlook of trauma products market?
• 3.What are the key factors driving the trauma products market?
• 4.Which region accounts for the largest trauma products market share?
• 5.Which are the leading companies in the global trauma products market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Trauma Products Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Internal Fixators
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Plates
    • 6.1.2.2 Screws
    • 6.1.2.3 Nails
    • 6.1.2.4 Others
  • 6.1.3 Market Forecast
• 6.2 External Fixators
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Unilateral and Bilateral External Fixators
    • 6.2.2.2 Circular External Fixators
    • 6.2.2.3 Hybrid External Fixators
  • 6.2.3 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Surgical Site

• 7.1 Upper Extremities
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Hand and Wrist
    • 7.1.2.2 Shoulder
    • 7.1.2.3 Elbow
  • 7.1.3 Market Forecast
• 7.2 Lower Extremities
  • 7.2.1 Market Trends
  • 7.2.2 Key Segments
    • 7.2.2.1 Hip and Pelvic
    • 7.2.2.2 Foot and Ankle
    • 7.2.2.3 Knee
    • 7.2.2.4 Others
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Trauma Centers
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgery Center
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Acumed LLC (Colson Medical Inc.)
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Arthrex Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 SWOT Analysis
  • 14.3.3 B. Braun Melsungen AG
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 SWOT Analysis
  • 14.3.4 Citieffe s.r.l
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Double Medical Technology Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Enovis Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Globus Medical Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Johnson & Johnson
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Medartis AG
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
  • 14.3.10 Orthofix Medical Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Smith & Nephew plc
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Stryker Corporation
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis
  • 14.3.13 Zimmer Biomet
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis